We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » In a Joint Meeting, Advisory Committees Recommend Approval of Abuse-Deterrent Opioid
In a Joint Meeting, Advisory Committees Recommend Approval of Abuse-Deterrent Opioid
In another attempt to quell the opioid abuse epidemic, two FDA advisory committees voted Wednesday to recommend approval of an NDA for an immediate-release opioid painkiller.